• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Susceptibility identification for seasonal influenza A/H3N2 based on baseline blood transcriptome

tetano

Editor, Senior Moderator
Front Immunol


. 2023 Jan 12;13:1048774.
doi: 10.3389/fimmu.2022.1048774. eCollection 2022.
Susceptibility identification for seasonal influenza A/H3N2 based on baseline blood transcriptome


Jing Tang[SUP] 1 2 [/SUP], Qiumei Xu[SUP] 2 3 [/SUP], Kang Tang[SUP] 1 2 [/SUP], Xiaoyan Ye[SUP] 4 [/SUP], Zicheng Cao[SUP] 2 5 [/SUP], Min Zou[SUP] 1 2 [/SUP], Jinfeng Zeng[SUP] 1 2 [/SUP], Xinyan Guan[SUP] 6 [/SUP], Jinglin Han[SUP] 1 2 [/SUP], Yihan Wang[SUP] 1 2 [/SUP], Lan Yang[SUP] 2 7 [/SUP], Yishan Lin[SUP] 1 2 [/SUP], Kaiao Jiang[SUP] 8 [/SUP], Xiaoliang Chen[SUP] 6 [/SUP], Yang Zhao[SUP] 1 2 [/SUP], Dechao Tian[SUP] 1 2 [/SUP], Chunwei Li[SUP] 4 [/SUP], Wei Shen[SUP] 9 [/SUP], Xiangjun Du[SUP] 1 2 10 [/SUP]



Affiliations
Free PMC article

Abstract

Introduction: Influenza susceptibility difference is a widely existing trait that has great practical significance for the accurate prevention and control of influenza.
Methods: Here, we focused on the human susceptibility to the seasonal influenza A/H3N2 of healthy adults at baseline level. Whole blood expression data for influenza A/H3N2 susceptibility from GEO were collected firstly (30 symptomatic and 19 asymptomatic). Then to explore the differences at baseline, a suite of systems biology approaches - the differential expression analysis, co-expression network analysis, and immune cell frequencies analysis were utilized.
Results: We found the baseline condition, especially immune condition between symptomatic and asymptomatic, was different. Co-expression module that is positively related to asymptomatic is also related to immune cell type of naïve B cell. Function enrichment analysis showed significantly correlation with "B cell receptor signaling pathway", "immune response-activating cell surface receptor signaling pathway" and so on. Also, modules that are positively related to symptomatic are also correlated to immune cell type of neutrophils, with function enrichment analysis showing significantly correlations with "response to bacterium", "inflammatory response", "cAMP-dependent protein kinase complex" and so on. Responses of symptomatic and asymptomatic hosts after virus exposure show differences on resisting the virus, with more effective frontline defense for asymptomatic hosts. A prediction model was also built based on only baseline transcription information to differentiate symptomatic and asymptomatic population with accuracy of 0.79.
Discussion: The results not only improve our understanding of the immune system and influenza susceptibility, but also provide a new direction for precise and targeted prevention and therapy of influenza.

Keywords: gene co-expression network; high-risk population prediction model; immune response; influenza A/H3N2; susceptibility.
 
Back
Top Bottom